Home Compare LEG.DE vs RPRX
Stock Comparison · Single-driver result

LEG Immobilien vs Royalty Pharma: Which Stock Looks Stronger in 2026?

The structural profiles are close, with LEG Immobilien SE carrying a narrow edge on stability. Royalty Pharma still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, Royalty Pharma carries the stronger setup — intact trend against LEG Immobilien SE's broken trend. That leaves a split case: the structural lead stays with LEG Immobilien SE, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The page question resolves through stability, where Royalty Pharma plc holds the stronger read even though the broader score still favours LEG Immobilien SE.

Trajectory Similarity
0.69
Moderately similar
Peer-set rank: #34
within LEG Immobilien SE's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

Most of the shared profile comes through investment intensity and margin consistency.

Similarity drivers
investment intensitymargin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
LEG.DE
LEG Immobilien SE
64
Peer-Score
Signal qualityMedium
vs
RPRX
Royalty Pharma plc
63
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: LEG.DE vs RPRX Profitability 71 68 Stability 29 75 Valuation 88 64 Growth 52 43 LEG.DE RPRX
Gap Ranking
#1 Stability +46
#2 Valuation +24
#3 Growth +9
#4 Profitability +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for LEG.DE and RPRX Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer LEG.DERPRX Relative valuation Structural strength

Royalty Pharma plc still looks cheaper, even though LEG Immobilien SE remains structurally stronger.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Royalty Pharma plc ranks near the top of the group on stability; LEG Immobilien SE sits in the weaker half.
Valuation
On valuation, the edge is clear — both rank well, but LEG Immobilien SE sits noticeably higher.
Stability — Dominant Gap
LEG.DE
29
RPRX
75
Gap+46in favour of RPRX

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

On the market side, Royalty Pharma carries the stronger trend while LEG Immobilien SE's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

Stability is the clearest driver of the lead, with valuation adding further support — though stability still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the LEG.DE vs RPRX comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how LEG.DE and RPRX each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.